Cardiology Update

JANUARY 2, 2024

Important Deadlines: 12 Feb ruary 2024 : Late-breaking science submissions 27 Feb ruary 2024 : Early Registration Savings 26 Mar 2024 : Late registration savings Fees: Visit the ESC Preventive Cardiology 2024 website for registration options. Hashtag: #ESCPrev2024 5. Hashtag: #HeartFailure2024 6.

Heart Failure 111

Heart Failure Atherosclerosis Cardiovascular Imaging Non-Invasive Cardiology 111

Cardiology Update

SEPTEMBER 24, 2024

Chadi Alraies discusses some of the important trials presented at the European Society of Cardiology 2024 congress. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The post ESC 2024 Highlights appeared first on Cardiology Update.

Research 130

Research Heart Failure Interventional Cardiology General Cardiology 130

All About Cardiovascular System and Disorders

MARCH 30, 2024

Electrophysiological study will show that, and this pathway can be ablated. Ebstein’s anomaly may present with a murmur for evaluation in the pediatric age group or in adults with arrhythmias or heart failure with cyanosis and exercise intolerance.

Tricuspid 52

Tricuspid Arrhythmia Congenital Heart Disease Electrophysiology 52

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

AF-CHF trial in those with AF and congestive heart failure also failed to show any advantage for the rhythm control strategy [3]. Overall, it appears that rhythm control strategy in AF may be better in those with heart failure and in those with associated cardiovascular conditions and early AF.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

Cardiology Update

APRIL 15, 2024

Chadi Alraies discusses the top impactful trials presented at the 2024 American College of Cardiology conference. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The post ACC 2024 Highlights appeared first on Cardiology Update.

Research 98

Research Heart Failure Interventional Cardiology General Cardiology 98

Cardiology Update

DECEMBER 3, 2023

Chadi Alraies discusses highlights from the American Heart Association (AHA) Scientific Sessions 2023, which were held in Philadelphia, Pennsylvania (PA), on November 11-13, 2023. There were many important developments in presented in key clinical trial presentations and publications stemming from the AHA Scientific Sessions 2023.

Research 98

Research Cardio Oncology COVID-19 Heart Failure 98

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52